Marc D. Beer, Chief Executive Officer at Aegerion Pharmaceuticals, Inc. (AEGR), sold 60,000 shares at $87.08 ($5.3M) on 2013-08-15, disclosed to the SEC on 2013-08-16.
Scheduled sale ($5.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.08 | 20,164 | $1.8M | 33.1% |
| 2 | $88.21 | 12,301 | $1.1M | 20.4% |
| 3 | $89.09 | 6,275 | $559K | 10.5% |
| 4 | $89.95 | 21,160 | $1.9M | 35.8% |
| 5 | $90.72 | 100 | $9K | 0.2% |
| Total | $88.54 avg | 60,000 |
| $5.3M |
| 100% |
| Filing → |
| BTMD | SELL | 2023-01-10 | $2.6M | — | Filing → |
| NERV | BUY | 2017-03-21 | $406K | — | Filing → |
| AEGR | BUY | 2014-07-31 | $337K | — | Filing → |